Highlights From ESMO Gastrointestinal Cancers Congress 2025
Following are key take‑home messages from ESMO GI 2025 (Barcelona, 2–5 July), organized by cancer type.
Highlights From ESMO Gastrointestinal Cancers Congress 2025 Read More »
ctDNA
What to Expect After a Cancer Diagnosis
This comprehensive guide will walk you through the essential steps to take immediately following your diagnosis, helping you move from initial shock to informed action while maintaining hope and agency throughout your cancer journey.
What to Expect After a Cancer Diagnosis Read More »
The Role of ctDNA/MRD Testing in Cancer: Promise, Practice, and Pitfalls
Circulating tumor DNA (ctDNA) and minimal residual disease (MRD) testing are rapidly transforming the landscape of cancer care. By offering a noninvasive window into the molecular status of a patient’s disease, these technologies are enabling earlier detection of recurrence, more precise monitoring of treatment response, and increasingly personalized therapeutic strategies.
The Role of ctDNA/MRD Testing in Cancer: Promise, Practice, and Pitfalls Read More »